Riskpilot← Back to searchSign inGet full accessCF Narken AB
ABActiveOrg 5564345717Vildkattsvägen 3General medical practice activities · NACE 8621Est. 19911 employees
Revenue 2024
SEK 1M
+289% vs 2023
EBITDA margin
-18.7%
+74% vs 2023
Equity ratio
75.4%
Financial strength
Net profit 2024
SEK -192K
+74% vs 2023
| Revenue | SEK 1M | +289% |
| EBITDA | SEK -193K | +74% |
| Net profit | SEK -192K | +74% |
| Total assets | SEK 732K | -31% |
| Equity | SEK 552K | -26% |
| Employees | 1 | — |
Legal name
CF Narken AB
Org number
5564345717
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 oktober 1991
Share capital
SEK 150 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är att bedriva avel, uppfödning, tränings- och tävlingsverksamhet med hästar, veterinärtjänster inom hästverksamhet och lantbruk, uthyrning av bostäder, lager, stall- och stallplatser, medicinsk konsultverksamhet såsom läkar- och sjukskötersketjänster ävensom idka därmed förenlig verksamhet.
Address
Vildkattsvägen 3
Phone
+4643115600
Email
caroline.hesselvall@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 285 | 566 | 1 325 | 265 | 1 031 |
| Staff expenses | — | — | — | — | −7 |
| EBITDA | −723 | −433 | 1 210 | −742 | −193 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −723 | −433 | 1 210 | −742 | −193 |
| Net financials | −194 | −29 | −621 | 1 | 0 |
| Profit before tax | −821 | −448 | 1 183 | −741 | −192 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −821 | −448 | 1 183 | −741 | −192 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 002 | 538 | 1 878 | 1 063 | 732 |
| Equity | 752 | 303 | 1 486 | 745 | 552 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 250 | 235 | 392 | 318 | 180 |
| Total debt | 250 | 235 | 392 | 318 | 180 |
EBITDA margin
-18.7%
This company
15.8%
Market median
-218% vs market
20202024
Equity ratio
75.4%
This company
38.2%
Market median
+97% vs market
20202024
Return on equity
-34.8%
This company
18.4%
Market median
-289% vs market
20202024
Net profit margin
-18.6%
This company
8.1%
Market median
-330% vs market
20202024
Asset turnover
1.41×
This company
1.12×
Market median
+26% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
BG Chief Executive Officer | Chief Executive Officer | 2020 – 2024 |
LÅ Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CF Narken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Gunnar Bertil Johansson | Chief Executive Officer | 0 companies |
| Lars Åke Anders Hjalmarsson | Chief Auditor | 0 companies |
| Mikael Dennis Hesselvall | Deputy Board Member | 0 companies |
| Fredrick Magnus Oscar Johansson | Board of Directors | 0 companies |
| Caroline Madeleine Hesselvall | Chairman | 0 companies |